Neuraminidase Inhibitors Flashcards
Neuraminidase Inhibitors
Oseltamivir
Peramivir
Zanamivir
Active against influenza A and B
Amantadine and Rimantidine active only against A
Prevent the viral neuraminidase enzyme from releasing new virions from the host cell which prevents further replication
Drugs differ in form of delivery Osel- oral pro drug Pera- IV Zan- inhaled Can be used as treatment or prophylaxis in those not able to get the vaccine
Neuraminidase Inhibitors MOA
Competitive inhibitors of viral neuraminidase, an enzyme responsible for several functions of the influenza virus including the release of new virions from infected cells
Neuraminidase Inhibitors Spectrum
Good
Influenza A and B
Poor
Other viruses
Neuraminidase Inhibitors Adverse Effects
Generally well tolerated
Osel can cause N/V, abdominal pain; tend to be transient effects
Headache and fatigue (particularly during prophylaxis when drug given for longer period of time)
Zan- mostly pulmonary (cough and bronchospasm)
Avoid use in asthma or other reactive pulmonary diseases
Per- limited experience; no characteristic adverse effects
Neuraminidase Inhibitors Important Facts
Most effective when started early in infection because viral replication peaks early (48-72 hours after infection)
Start in patients who have been symptomatic for no more than 2 days (based on indication for mild-mod disease in healthy adults
In severe disease (hospitalization or vulnerable patients) data suggests may be beneficial if started outside this window
Resistance can occur
Utility dictated by degree of resistance that exists in the dominant strains of the season
Zan active against majority of strains resistant to the other two but patterns may change
Osel and Zan are highly effective at prophylaxis when predominant strains in the community are susceptible; not a substitute for the vaccine
Adverse effects more common with the longer duration prophylaxis than shorter duration treatment
All 3 effective at treating and preventing influenza if circulating strains are susceptible
Vast majority of data is with uncomplicated patients
Desired route of administration decided what drug to use